| . | Sex . | |
|---|---|---|
| . | Female . | Male . |
| Total number of participants | 3585 (52.8%) | 3200 (47.2%) |
| Fat mass (kg) | 30.66 (11.56) | 23.35 (8.82) |
| Fat-free mass (kg) | 43.05 (6.59) | 60.78 (8.72) |
| Weight (kg) | 73.71 (17.19) | 84.13 (15.75) |
| Height (m) | 1.60 (0.07) | 1.74 (0.08) |
| Body mass index (kg/m2) | 28.76 (6.23) | 27.85 (4.45) |
| Waist (cm) | 97.14 (16.03) | 99.26 (12.24) |
| Waist-to-height ratio | 0.61 (0.10) | 0.57 (0.07) |
| Age at Exam 1 | 62.12 (10.27) | 62.18 (10.22) |
| Race/ethnicity | ||
| White | 1360 (37.9%) | 1254 (39.2%) |
| Chinese American | 412 (11.5%) | 389 (12.2%) |
| African American | 1042 (29.1%) | 838 (26.2%) |
| Hispanic | 771 (21.5%) | 719 (22.5%) |
| Taking diabetes medication | ||
| No | 3263 (91.0%) | 2865 (89.5%) |
| Yes | 322 (9.0%) | 335 (10.5%) |
| Cigarettes: smoked in last 30 days | ||
| No | 3165 (88.3%) | 2733 (85.4%) |
| Yes | 420 (11.7%) | 467 (14.6%) |
| HDL cholesterol (mg/dL) | 56.26 (15.29) | 45.07 (11.78) |
| LDL cholesterol (mg/dL) | 199.59 (35.62) | 188.05 (34.83) |
| Any lipid-lowering medication | ||
| No | 2997 (83.8%) | 2672 (83.7%) |
| Yes | 580 (16.2%) | 521 (16.3%) |
| Systolic blood pressure (mmHg) | 127.07 (23.21) | 126.05 (19.36) |
| Any hypertension medication | ||
| No | 2203 (61.5%) | 2052 (64.1%) |
| Yes | 1379 (38.5%) | 1148 (35.9%) |
| Family history of heart attack | ||
| No | 2028 (56.6%) | 2033 (63.5%) |
| Yes | 1557 (43.4%) | 1167 (36.5%) |
| . | Sex . | |
|---|---|---|
| . | Female . | Male . |
| Total number of participants | 3585 (52.8%) | 3200 (47.2%) |
| Fat mass (kg) | 30.66 (11.56) | 23.35 (8.82) |
| Fat-free mass (kg) | 43.05 (6.59) | 60.78 (8.72) |
| Weight (kg) | 73.71 (17.19) | 84.13 (15.75) |
| Height (m) | 1.60 (0.07) | 1.74 (0.08) |
| Body mass index (kg/m2) | 28.76 (6.23) | 27.85 (4.45) |
| Waist (cm) | 97.14 (16.03) | 99.26 (12.24) |
| Waist-to-height ratio | 0.61 (0.10) | 0.57 (0.07) |
| Age at Exam 1 | 62.12 (10.27) | 62.18 (10.22) |
| Race/ethnicity | ||
| White | 1360 (37.9%) | 1254 (39.2%) |
| Chinese American | 412 (11.5%) | 389 (12.2%) |
| African American | 1042 (29.1%) | 838 (26.2%) |
| Hispanic | 771 (21.5%) | 719 (22.5%) |
| Taking diabetes medication | ||
| No | 3263 (91.0%) | 2865 (89.5%) |
| Yes | 322 (9.0%) | 335 (10.5%) |
| Cigarettes: smoked in last 30 days | ||
| No | 3165 (88.3%) | 2733 (85.4%) |
| Yes | 420 (11.7%) | 467 (14.6%) |
| HDL cholesterol (mg/dL) | 56.26 (15.29) | 45.07 (11.78) |
| LDL cholesterol (mg/dL) | 199.59 (35.62) | 188.05 (34.83) |
| Any lipid-lowering medication | ||
| No | 2997 (83.8%) | 2672 (83.7%) |
| Yes | 580 (16.2%) | 521 (16.3%) |
| Systolic blood pressure (mmHg) | 127.07 (23.21) | 126.05 (19.36) |
| Any hypertension medication | ||
| No | 2203 (61.5%) | 2052 (64.1%) |
| Yes | 1379 (38.5%) | 1148 (35.9%) |
| Family history of heart attack | ||
| No | 2028 (56.6%) | 2033 (63.5%) |
| Yes | 1557 (43.4%) | 1167 (36.5%) |
Family history includes parents, children, or siblings.
HDL, high-density lipoprotein; LDL, low-density lipoprotein; MESA, multi-ethnic study of atherosclerosis.
| . | Sex . | |
|---|---|---|
| . | Female . | Male . |
| Total number of participants | 3585 (52.8%) | 3200 (47.2%) |
| Fat mass (kg) | 30.66 (11.56) | 23.35 (8.82) |
| Fat-free mass (kg) | 43.05 (6.59) | 60.78 (8.72) |
| Weight (kg) | 73.71 (17.19) | 84.13 (15.75) |
| Height (m) | 1.60 (0.07) | 1.74 (0.08) |
| Body mass index (kg/m2) | 28.76 (6.23) | 27.85 (4.45) |
| Waist (cm) | 97.14 (16.03) | 99.26 (12.24) |
| Waist-to-height ratio | 0.61 (0.10) | 0.57 (0.07) |
| Age at Exam 1 | 62.12 (10.27) | 62.18 (10.22) |
| Race/ethnicity | ||
| White | 1360 (37.9%) | 1254 (39.2%) |
| Chinese American | 412 (11.5%) | 389 (12.2%) |
| African American | 1042 (29.1%) | 838 (26.2%) |
| Hispanic | 771 (21.5%) | 719 (22.5%) |
| Taking diabetes medication | ||
| No | 3263 (91.0%) | 2865 (89.5%) |
| Yes | 322 (9.0%) | 335 (10.5%) |
| Cigarettes: smoked in last 30 days | ||
| No | 3165 (88.3%) | 2733 (85.4%) |
| Yes | 420 (11.7%) | 467 (14.6%) |
| HDL cholesterol (mg/dL) | 56.26 (15.29) | 45.07 (11.78) |
| LDL cholesterol (mg/dL) | 199.59 (35.62) | 188.05 (34.83) |
| Any lipid-lowering medication | ||
| No | 2997 (83.8%) | 2672 (83.7%) |
| Yes | 580 (16.2%) | 521 (16.3%) |
| Systolic blood pressure (mmHg) | 127.07 (23.21) | 126.05 (19.36) |
| Any hypertension medication | ||
| No | 2203 (61.5%) | 2052 (64.1%) |
| Yes | 1379 (38.5%) | 1148 (35.9%) |
| Family history of heart attack | ||
| No | 2028 (56.6%) | 2033 (63.5%) |
| Yes | 1557 (43.4%) | 1167 (36.5%) |
| . | Sex . | |
|---|---|---|
| . | Female . | Male . |
| Total number of participants | 3585 (52.8%) | 3200 (47.2%) |
| Fat mass (kg) | 30.66 (11.56) | 23.35 (8.82) |
| Fat-free mass (kg) | 43.05 (6.59) | 60.78 (8.72) |
| Weight (kg) | 73.71 (17.19) | 84.13 (15.75) |
| Height (m) | 1.60 (0.07) | 1.74 (0.08) |
| Body mass index (kg/m2) | 28.76 (6.23) | 27.85 (4.45) |
| Waist (cm) | 97.14 (16.03) | 99.26 (12.24) |
| Waist-to-height ratio | 0.61 (0.10) | 0.57 (0.07) |
| Age at Exam 1 | 62.12 (10.27) | 62.18 (10.22) |
| Race/ethnicity | ||
| White | 1360 (37.9%) | 1254 (39.2%) |
| Chinese American | 412 (11.5%) | 389 (12.2%) |
| African American | 1042 (29.1%) | 838 (26.2%) |
| Hispanic | 771 (21.5%) | 719 (22.5%) |
| Taking diabetes medication | ||
| No | 3263 (91.0%) | 2865 (89.5%) |
| Yes | 322 (9.0%) | 335 (10.5%) |
| Cigarettes: smoked in last 30 days | ||
| No | 3165 (88.3%) | 2733 (85.4%) |
| Yes | 420 (11.7%) | 467 (14.6%) |
| HDL cholesterol (mg/dL) | 56.26 (15.29) | 45.07 (11.78) |
| LDL cholesterol (mg/dL) | 199.59 (35.62) | 188.05 (34.83) |
| Any lipid-lowering medication | ||
| No | 2997 (83.8%) | 2672 (83.7%) |
| Yes | 580 (16.2%) | 521 (16.3%) |
| Systolic blood pressure (mmHg) | 127.07 (23.21) | 126.05 (19.36) |
| Any hypertension medication | ||
| No | 2203 (61.5%) | 2052 (64.1%) |
| Yes | 1379 (38.5%) | 1148 (35.9%) |
| Family history of heart attack | ||
| No | 2028 (56.6%) | 2033 (63.5%) |
| Yes | 1557 (43.4%) | 1167 (36.5%) |
Family history includes parents, children, or siblings.
HDL, high-density lipoprotein; LDL, low-density lipoprotein; MESA, multi-ethnic study of atherosclerosis.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
